2015
DOI: 10.1074/jbc.m114.612754
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Multicellular Aggregation in the Survival of ErbB2-positive Breast Cancer Cells during Extracellular Matrix Detachment

Abstract: Background: Cancer cells evade death caused by extracellular matrix (ECM)-detachment to facilitate metastasis. Results: ErbB2-expressing cancer cells form aggregates during ECM-detachment that promote survival signaling through EGFR. Conclusion: Multicellular aggregation in ErbB2 positive cancer cells promotes survival by preventing EGFR degradation. Significance: Disrupting aggregation or inhibiting EGFR may be effective strategies to eliminate ErbB2-expressing cancer cells during ECM-detachment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
28
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 38 publications
(29 citation statements)
references
References 53 publications
1
28
0
Order By: Relevance
“…Since anoikis prevents anchorage-independent proliferation and attachment to an improper matrix, it is generally considered as an oncosuppressive process [ 234 , 236 ]. Accordingly, cancer cells need to acquire at least some degree of resistance to anoikis to initiate and progress though the so-called “metastatic cascade” [ 237 239 ]. Neoplastic cells can evade anoikis upon activation of mitogen-activated protein kinase 1 (MAPK1; best known as ERK2) caused by cellular aggregation and consequent epidermal growth factor receptor (EGFR) stabilization mediated by erb-b2 receptor tyrosine kinase 2 (ERBB2) [ 237 , 240 ], or degradation of the negative ERK2 regulator BRCA1-associated protein (BRAP), which is favored by coiled-coil domain containing 178 (CCDC178) [ 241 ].…”
Section: Intrinsic Apoptosismentioning
confidence: 99%
“…Since anoikis prevents anchorage-independent proliferation and attachment to an improper matrix, it is generally considered as an oncosuppressive process [ 234 , 236 ]. Accordingly, cancer cells need to acquire at least some degree of resistance to anoikis to initiate and progress though the so-called “metastatic cascade” [ 237 239 ]. Neoplastic cells can evade anoikis upon activation of mitogen-activated protein kinase 1 (MAPK1; best known as ERK2) caused by cellular aggregation and consequent epidermal growth factor receptor (EGFR) stabilization mediated by erb-b2 receptor tyrosine kinase 2 (ERBB2) [ 237 , 240 ], or degradation of the negative ERK2 regulator BRCA1-associated protein (BRAP), which is favored by coiled-coil domain containing 178 (CCDC178) [ 241 ].…”
Section: Intrinsic Apoptosismentioning
confidence: 99%
“…6 These data suggest that the strategies used by cancer cells to alleviate deleterious metabolic changes (and block anoikis) may vary considerably across tumor types and contexts. 11,29,30 Additional studies examining the relationship between oncogenic signaling and metabolism in ECM-detached cancer cells are warranted to better ascertain the best strategies to facilitate their elimination.…”
Section: Discussionmentioning
confidence: 99%
“…Oftentimes, these modifications in survival signaling converge on the Bcl-2 family of proteins which modulate the release of cytochrome c from the intermembrane space. Multiple signaling pathways regulating mitochondrial permeabilization during anoikis have been unveiled in numerous and disparate contexts (5)(6)(7)(8)(9)(10)(11)(12). A fundamental implication of these findings is that cancer cells can employ a multi-faceted arsenal of diverse and overlapping strategies to block anoikis induction leading to their survival.…”
Section: Introductionmentioning
confidence: 99%